Puluo Pharmaceutical: Completed a stock buyback of 150 million yuan, accounting for 0.90% of the total share capital.

Pro Pharmaceutical announced that from April 30, 2025 to November 12, 2025, the company has repurchased a total of 10,442,300 shares through centralized bidding trading, accounting for 0.90% of the total share capital. The highest transaction price was 15.59 yuan per share, and the lowest transaction price was 13.62 yuan per share, with a total transaction amount of 150 million yuan, funded by own funds and financial institution loans. This repurchase complies with the plan and regulatory requirements, has no significant impact on various aspects of the company, and does not affect its listing status. The repurchased shares are intended for stock incentives or employee shareholding plans. If not implemented within 36 months, the unused portion will be cancelled.